Association of vitamin A and its organic compounds with stroke – a systematic review and meta-analysis

References

• Donkor ES. Stroke in the 21(st) century: a snapshot of the burden, epidemiology, and quality of life. Stroke Res Treat. 2018;2018:3238165.
   PubMed Web of Science ®Google Scholar
• Kumar S, Selim MH, Caplan LR. Medical complications after stroke. Lancet Neurol. 2010;9:105–18.
   PubMed Web of Science ®Google Scholar
• Boehme AK, Esenwa C, Elkind MSV. Stroke risk factors, genetics, and prevention. Circ Res. 2017;120:472–95.
   PubMed Web of Science ®Google Scholar
• Fekadu G, Chelkeba L, Kebede A. Risk factors, clinical presentations and predictors of stroke among adult patients admitted to stroke unit of Jimma University Medical Center, south west Ethiopia: prospective observational study. BMC Neurol. 2019;19:187.
   PubMedGoogle Scholar
• Li R-C, Xu W-D, Lei Y-L, Bao T, Yang H-W, Huang W-X, etal The risk of stroke and associated risk factors in a health examination population: a cross-sectional study. Medicine. 2019;98:e17218.
   PubMed Web of Science ®Google Scholar
• Chang CY, Chen JY, Ke D, Hu ML. Plasma levels of lipophilic antioxidant vitamins in acute ischemic stroke patients: correlation to inflammation markers and neurological deficits. Nutrition. 2005;21:987–93.
   PubMed Web of Science ®Google Scholar
• Alawneh KZ, Al Qawasmeh M, Raffee LA, Abuzayed B, Bani Hani DA, Abdalla KM, et al. A snapshot of Ischemic stroke risk factors, sub-types, and its epidemiology: cohort study. Ann Med Surg. 2020;59:101–5.
   PubMed Web of Science ®Google Scholar
• Shah RS, Cole JW. Smoking and stroke: the more you smoke the more you stroke. Expert Rev Cardiovasc Ther. 2010;8:917–32.
   PubMedGoogle Scholar
• Chang CY, Lai YC, Cheng TJ, Lau MT, Hu ML. Plasma levels of antioxidant vitamins, selenium, total sulfhydryl groups and oxidative products in ischemic-stroke patients as compared to matched controls in Taiwan. Free Radic Res. 1998;28:15–24.
   PubMed Web of Science ®Google Scholar
• Cherubini A, Polidori MC, Bregnocchi M, Pezzuto S, Cecchetti R, Ingegni T, et al. Antioxidant profile and early outcome in stroke patients. Stroke. 2000;31:2295–300.
   PubMed Web of Science ®Google Scholar
• Rodrigo R, Fernández-Gajardo R, Gutiérrez R, Matamala JM, Carrasco R, Miranda-Merchak A, et al. Oxidative stress and pathophysiology of ischemic stroke: novel therapeutic opportunities. CNS Neurol Disord Drug Targets. 2013;12:698–714.
   PubMed Web of Science ®Google Scholar
• De Keyser J, De Klippel N, Merkx H, Vervaeck M, Herroelen L. Serum concentrations of vitamins A and E and early outcome after ischaemic stroke. Lancet. 1992;339:1562–5.
   PubMed Web of Science ®Google Scholar
• Chang CY, Lai YC, Cheng TJ, Hu ML. Plasma status of antioxidant vitamins and oxidative products in ischemic-stroke patients during early post-stroke stage. J Appl Nutr. 1997;49:77–83.
   Google Scholar
• Yu YR, Zhang H, Song Y, Lin TF, Zhou ZY, Guo HY, et al. Plasma retinol and the risk of first stroke in hypertensive adults: a nested case-control study. Am J Clin Nutr. 2019;109:449–56.
   PubMed Web of Science ®Google Scholar
• Kadri A, Sjahrir H, Juwita Sembiring R, Ichwan M. Combination of vitamin A and D supplementation for ischemic stroke: effects on interleukin-1ß and clinical outcome. Med Glas. 2020;17:425–32.
   Google Scholar
• Li H, He P, Lin T, Guo H, Li Y, Song Y, et al. Association between plasma retinol levels and the risk of all-cause mortality in general hypertensive patients: a nested case-control study. J Clin Hypertens. 2020;22:906–13.
   Web of Science ®Google Scholar
• Guo LJ, Huang Y, Wan R, Shen Y, Hong K. Increased blood retinol levels are associated with a reduced risk of TIA or stroke in an adult population: lifestyle factors- and CVDs-stratified analysis. Front Cardiovasc Med. 2021;8:744611.
   PubMed Web of Science ®Google Scholar
• Hak AE, Ma J, Powell CB, Campos H, Gaziano JM, Willett WC, Stampfer MJ. Prospective study of plasma carotenoids and tocopherols in relation to risk of ischemic stroke. Stroke. 2004;35:1584–8.
   PubMed Web of Science ®Google Scholar
• Karppi J, Laukkanen JA, Sivenius J, Ronkainen K, Kurl S. Serum lycopene decreases the risk of stroke in men: a population-based follow-up study. Neurology. 2012;79:1540–7.
   PubMed Web of Science ®Google Scholar
• Liang X, Chen M, Qu P, Hao G, Huang Y, Chen J, Li T. The association of vitamin A and vitamin D with hypertension in children: a case-control study. Int J Hypertens. 2018;2018:1–8.
   Web of Science ®Google Scholar
• Horie S, Kizaki K, Ishii H, Kazama M. Retinoic acid stimulates expression of thrombomodulin, a cell surface anticoagulant glycoprotein, on human endothelial cells. Differences between up-regulation of thrombomodulin by retinoic acid and cyclic AMP. Biochem J. 1992;281(Pt 1):149–54.
   PubMedGoogle Scholar
• Brinckerhoff CE, Coffey JW, Sullivan AC. Inflammation and collagenase production in rats with adjuvant arthritis reduced with 13-cis-retinoic acid. Science. 1983;221:756–8.
   PubMed Web of Science ®Google Scholar
• Relevy NZ, Harats D, Harari A, Ben-Amotz A, Bitzur R, Rühl R, Shaish A. Vitamin A-deficient diet accelerated atherogenesis in apolipoprotein E−/− mice and dietary β-carotene prevents this consequence. Biomed Res Int. 2015;2015:1–9.
   Web of Science ®Google Scholar
• Tu WJ, Qiu HC, Zhang YQ, Cao JL, Wang H, Zhao JZ, et al. Lower serum retinoic acid level for prediction of higher risk of mortality in ischemic stroke. Neurology. 2019;92:E1678–87.
   PubMed Web of Science ®Google Scholar
• Xu M, Xu L, Du H, Shan W, Feng J, Zhai G, Yang X. Decreased serum retinoic acid may predict poor outcome in ischemic stroke patients. Neuropsychiatr Dis Treat. 2020;16:1483–91.
   PubMed Web of Science ®Google Scholar
• Berard A, Azoulay L, Nakhai-Pour HR, Moussally K. Isotretinoin and the risk of cardiovascular, cerebrovascular and thromboembolic disorders. Dermatology. 2011;223:45–51.
   PubMed Web of Science ®Google Scholar
• Yochum LA, Folsom AR, Kushi LH. Intake of antioxidant vitamins and risk of death from stroke in postmenopausal women. Am J Clin Nutr. 2000;72:476–83.
   PubMed Web of Science ®Google Scholar
• Bang OY, Chung JW, Lee MJ, Seo WK, Kim GM, Ahn MJ. Cancer-related stroke: an emerging subtype of ischemic stroke with unique pathomechanisms. J Stroke. 2020;22:1–10.
   PubMed Web of Science ®Google Scholar
• Cumming G. Understanding the new statistics: effect sizes, confidence intervals, and meta-analysis. New York: Routledge/Taylor & Francis Group; 2012.
   Google Scholar
• Hasselblad V, Hedges LV. Meta-analysis of screening and diagnostic tests. Psychol Bull. 1995;117:167–78.
   PubMed Web of Science ®Google Scholar
• Sánchez-Meca J, Marín-Martínez F, Chacón-Moscoso S. Effect-size indices for dichotomized outcomes in meta-analysis. Psychol Methods. 2003;8:448–67.
   PubMed Web of Science ®Google Scholar
• Zhang J, Yu KF. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280:1690–1.
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.
   PubMed Web of Science ®Google Scholar
• Biggerstaff BJ, Tweedie RL. Incorporating variability in estimates of heterogeneity in the random effects model in meta-analysis. Stat Med. 1997;16:753–68.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.
   PubMed Web of Science ®Google Scholar
• Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–101.
   PubMed Web of Science ®Google Scholar
• Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, etal. 2000 The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available from: URL: http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm
   Google Scholar
• Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.
   PubMed Web of Science ®Google Scholar
• Ma L-L, Wang Y-Y, Yang Z-H, Huang D, Weng H, Zeng X-T. Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better? Mil Med Res. 2020;7:7.
   PubMed Web of Science ®Google Scholar
• Keli SO, Hertog MGL, Feskens EJM, Kromhout D, Flavonoids D, Vitamins A. Dietary flavonoids, antioxidant vitamins, and incidence of stroke. Arch Intern Med. 1996;156:637–42.
   PubMed Web of Science ®Google Scholar
• Chen YC, Chen CM, Liu JL, Chen ST, Cheng ML, Chiu DTY. Oxidative markers in spontaneous intracerebral hemorrhage: leukocyte 8-hydroxy-2 ‘-deoxyguanosine as an independent predictor of the 30-day outcome clinical article. J Neurosurg. 2011;115:1184–90.
   PubMed Web of Science ®Google Scholar
• Gey KF, Stähelin HB, Eichholzer M. Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke Basel prospective study. Clin Investig. 1993;71:3–6.
   PubMedGoogle Scholar
• Ozbey U, Seyran A, Erisir M, Ozel S. Oxidative stress and altered levels of oxidants and antioxidants in acute ischemic stroke patients in a region of East Turkey. HealthMED. 2012;6:1574–82.
   Google Scholar
• Daviglus ML, Orencia AJ, Dyer AR, Liu K, Morris DK, Persky V, et al. Dietary vitamin C, beta-carotene and 30-year risk of stroke: results from the western electric study. Neuroepidemiology. 1997;16:69–77.
   PubMed Web of Science ®Google Scholar
• Zhu YY, Zhang JL, Liu L, Han Y, Ge X, Zhao S. Evaluation of serum retinol-binding protein-4 levels as a biomarker of poor short-term prognosis in ischemic stroke. Biosci Rep. 2018;38:BSR20180786.
   PubMed Web of Science ®Google Scholar
• Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med. 1996;334:1145–9.
   PubMed Web of Science ®Google Scholar
• Llombart V, García-Berrocoso T, Bustamante A, Giralt D, Rodriguez-Luna D, Muchada M, et al. Plasmatic retinol-binding protein 4 and glial fibrillary acidic protein as biomarkers to differentiate ischemic stroke and intracerebral hemorrhage. J Neurochem. 2016;136:416–24.
   PubMed Web of Science ®Google Scholar
• Prentice RL, Paczesny S, Aragaki A, Amon LM, Chen L, Pitteri SJ, et al. Novel proteins associated with risk for coronary heart disease or stroke among postmenopausal women identified by in-depth plasma proteome profiling. Genome Med. 2010;2:48.
   PubMed Web of Science ®Google Scholar
• Rist PM, Jiménez MC, Tworoger SS, Hu FB, Manson JE, Sun Q, Rexrode KM. Plasma retinol-binding protein 4 levels and the risk of ischemic stroke among women. J Stroke Cerebrovasc Dis. 2018;27:68–75.
   PubMed Web of Science ®Google Scholar
• Weng S. The health and economic costs of smoking in the workforce: premature mortality, sickness absence and workplace interventions for smoking cessation. Nottingham (UK): University of Nottingham; 2013.
   Google Scholar
• Verde PE. A bias-corrected meta-analysis model for combining, studies of different types and quality. Biom J. 2021;63:406–22.
   PubMed Web of Science ®Google Scholar
• Kurth T, Gaziano JM, Berger K, Kase CS, Rexrode KM, Cook NR, et al. Body mass index and the risk of stroke in men. Arch Intern Med. 2002;162:2557–62.
   PubMed Web of Science ®Google Scholar
• Parthasarathy S, Steinberg D, Witztum J. The role of oxidized low density lipoproteins in the pathogenesis of atherosclerosis. Annu Rev Med Glas. 1992;43:219–25.
   PubMed Web of Science ®Google Scholar
• Jin R, Liu L, Zhang S, Nanda A, Li G. Role of inflammation and its mediators in acute ischemic stroke. J Cardiovasc Transl Res. 2013;6:834–51.
   PubMed Web of Science ®Google Scholar
• Abdelhamid L, Hussein H, Ghanem M, Eissa N. Retinoic acid-mediated anti-inflammatory responses in equine immune cells stimulated by lps and allogeneic mesenchymal stem cells. Res Vet Sci. 2017;114:225–32.
   PubMed Web of Science ®Google Scholar
• Guleria R, Pan J, Dipette D, Singh U. Hyperglycemia inhibits retinoic acid-induced activation of rac1, prevents differentiation of cortical neurons, and causes oxidative stress in a rat model of diabetic pregnancy. Diabetes. 2006;55:3326–34.
   PubMed Web of Science ®Google Scholar
• Chadwick CC, Shaw LJ, Winneker RC. TNF-alpha and 9-cis-retinoic acid synergistically induce ICAM-1 expression: evidence for interaction of retinoid receptors with NF-kappa B. Exp Cell Res. 1998;239:423–9.
   PubMed Web of Science ®Google Scholar
• Gey KF, Moser UK, Jordan P, Stähelin HB, Eichholzer M, Lüdin E. Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: an epidemiological update with special attention to carotene and vitamin C. Am J Clin Nutr. 1993;57:787s–97s.
   PubMed Web of Science ®Google Scholar
• Farashi S. Analysis of vertical eye movements in Parkinson’s disease and its potential for diagnosis. Appl Intell. 2021;51:8260–70.
   Web of Science ®Google Scholar
• Farashi S, Khosrowabadi R. EEG based emotion recognition using minimum spanning tree. Phys Eng Sci Med. 2020;43:985–96.
   PubMedGoogle Scholar
• Farashi S. Distinguishing between Parkinson’s disease patients and healthy individuals using a comprehensive set of time, frequency and time-frequency features extracted from vertical ground reaction force data. Biomed Signal Process Control. 2020;62:102132.
   Web of Science ®Google Scholar